These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2412297)

  • 1. Clinical use of heparin fractions, fragments, and heparinoids.
    Messmore HL
    Semin Thromb Hemost; 1985 Apr; 11(2):208-12. PubMed ID: 2412297
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
    Rowlings PA; Mansberg R; Rozenberg MC; Evans S; Murray B
    Aust N Z J Med; 1991 Feb; 21(1):52-4. PubMed ID: 1709804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
    Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
    Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
    Nurmohamed MT; Fareed J; Hoppensteadt D; Walenga JM; ten Cate JW
    Semin Thromb Hemost; 1991; 17 Suppl 2():205-13. PubMed ID: 1948091
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative review of the adverse effect profiles of heparins and heparinoids.
    Borris LC; Lassen MR
    Drug Saf; 1995 Jan; 12(1):26-31. PubMed ID: 7537967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
    Doherty DC; Ortel TL; de Bruijn N; Greenberg CS; Van Trigt P
    Anesthesiology; 1990 Sep; 73(3):562-5. PubMed ID: 1697448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
    Chong BH; Jacques T
    Intensive Care Med; 1991; 17(7):437. PubMed ID: 1774405
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of a low molecular weight preparation of heparin--ORG 10172 (Lomoparan) in the critically ill.
    John G; Shehabi Y; Mudaliar Y
    Anaesth Intensive Care; 1991 Nov; 19(4):588-91. PubMed ID: 1721505
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
    Harenberg J; Zimmermann R; Schwarz F; Kübler W
    Lancet; 1983 Apr; 1(8331):986-7. PubMed ID: 6132291
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
    Cola C; Ansell J
    Am Heart J; 1990 Feb; 119(2 Pt 1):368-74. PubMed ID: 1689094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
    Kikta MJ; Keller MP; Humphrey PW; Silver D
    Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
    van Besien K; Hoffman R; Golichowski A
    Thromb Res; 1991 Apr; 62(1-2):23-9. PubMed ID: 1712988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.
    Meuleman DG
    Semin Thromb Hemost; 1989 Oct; 15(4):370-2. PubMed ID: 2479103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
    Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
    Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172).
    Magnani HN
    Thromb Haemost; 1993 Oct; 70(4):554-61. PubMed ID: 7509508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
    ten Cate JW
    Haemostasis; 1992; 22(2):109-11. PubMed ID: 1379964
    [No Abstract]   [Full Text] [Related]  

  • 17. Orgaran (Org 10172): its pharmacological profile in experimental models.
    Meuleman DG
    Haemostasis; 1992; 22(2):58-65. PubMed ID: 1379965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparinoids Danaparoid and Sulodexide as clinically used drugs.
    Dou H; Song A; Jia S; Zhang L
    Prog Mol Biol Transl Sci; 2019; 163():55-74. PubMed ID: 31030761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orgaran in heparin-induced thrombocytopenia.
    Chong BH; Magnani HN
    Haemostasis; 1992; 22(2):85-91. PubMed ID: 1379968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
    Christiansen S; Geiger A; Splittgerber FH; Reidemeister JC
    Cardiovasc Surg; 1998 Feb; 6(1):90-3. PubMed ID: 9546852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.